1. Home
  2. CTMX vs JVSA Comparison

CTMX vs JVSA Comparison

Compare CTMX & JVSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • JVSA
  • Stock Information
  • Founded
  • CTMX 2008
  • JVSA 2021
  • Country
  • CTMX United States
  • JVSA Hong Kong
  • Employees
  • CTMX 122
  • JVSA N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • JVSA
  • Sector
  • CTMX Health Care
  • JVSA
  • Exchange
  • CTMX Nasdaq
  • JVSA NYSE
  • Market Cap
  • CTMX 62.3M
  • JVSA 80.7M
  • IPO Year
  • CTMX 2015
  • JVSA 2024
  • Fundamental
  • Price
  • CTMX $0.80
  • JVSA $10.58
  • Analyst Decision
  • CTMX Buy
  • JVSA
  • Analyst Count
  • CTMX 6
  • JVSA 0
  • Target Price
  • CTMX $5.77
  • JVSA N/A
  • AVG Volume (30 Days)
  • CTMX 730.8K
  • JVSA 28.5K
  • Earning Date
  • CTMX 03-10-2025
  • JVSA 01-01-0001
  • Dividend Yield
  • CTMX N/A
  • JVSA N/A
  • EPS Growth
  • CTMX N/A
  • JVSA N/A
  • EPS
  • CTMX 0.16
  • JVSA 0.24
  • Revenue
  • CTMX $126,617,000.00
  • JVSA N/A
  • Revenue This Year
  • CTMX $22.55
  • JVSA N/A
  • Revenue Next Year
  • CTMX N/A
  • JVSA N/A
  • P/E Ratio
  • CTMX $5.14
  • JVSA $43.72
  • Revenue Growth
  • CTMX 33.66
  • JVSA N/A
  • 52 Week Low
  • CTMX $0.75
  • JVSA $10.02
  • 52 Week High
  • CTMX $5.85
  • JVSA $10.64
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 41.61
  • JVSA N/A
  • Support Level
  • CTMX $0.75
  • JVSA N/A
  • Resistance Level
  • CTMX $0.98
  • JVSA N/A
  • Average True Range (ATR)
  • CTMX 0.06
  • JVSA 0.00
  • MACD
  • CTMX 0.00
  • JVSA 0.00
  • Stochastic Oscillator
  • CTMX 20.13
  • JVSA 0.00

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About JVSA JVSPAC ACQUISITION CORP

JVSPAC Acquisition Corp is blank check company.

Share on Social Networks: